SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-21-132349
Filing Date
2021-11-01
Accepted
2021-11-01 16:10:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2129373-3_s1a.htm 424B3 534659
2 GRAPHIC lg_nabriva-4c.jpg GRAPHIC 78973
  Complete submission text file 0001104659-21-132349.txt   644414
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-260146 | Film No.: 211367244
SIC: 2834 Pharmaceutical Preparations